Pentostatin, cyclophosphamide, and rituximab show significant clinical activity in patients with previously untreated chronic lymphocytic leukemia
Curr Oncol Rep
.
2007 Sep;9(5):335-6; discussion 336.
doi: 10.1007/s11912-007-0044-x.
Authors
Nicole Lamanna
,
Mark A Weiss
PMID:
17706160
DOI:
10.1007/s11912-007-0044-x
No abstract available